Cyclic amides (including cyclic carbamates) and their derivatives: 2-acetamidobenzoic acid (N-acetylanthranillic acid) and its salts

In 2024, cyclic amides (including cyclic carbamates) and their derivatives: 2-acetamidobenzoic acid (n-acetylanthranillic acid) and its salts trade exhibited significant decline, with global flows reaching $574,577 and a three-year compound annual growth rate of -27.6% (five-year: -11.7%). The all-time peak of $26,758,299 was recorded in 2002; the current level is 98% below that high-water mark.

Over the 30-year observation window (1995–2024), 45% of years recorded positive growth, indicating significant cyclicality with frequent contractions. Trend momentum is decelerating (-14.4% acceleration).

The supply side is moderately concentrated (Herfindahl-Hirschman Index 0.249). The three largest exporters — United Kingdom ($1.9M), United States ($1.8M), and Italy ($1.7M) — collectively dominate supply flows. The leading exporter has grown at +4.8% over the last three years.

On the demand side, importer concentration is moderately concentrated (HHI 0.246). The three largest import markets are Tunisia ($204.6K), Ireland ($192.2K), and Kuwait ($80.0K). The largest importing market sources from 3 different supplying countries.

The dominant trade corridor is United Kingdom → France at $1.6M, representing 100.0% of the importer's total demand.

The volatility score for cyclic amides (including cyclic carbamates) and their derivatives: 2-acetamidobenzoic acid (n-acetylanthranillic acid) and its salts is 17 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, contracting demand signals caution before committing resources. A moderately concentrated market rewards differentiated positioning and strategic partner selection.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.